3 Recruiting Malignant Melanoma Phase 2 Clinical Trials
Active phase 2 studies for malignant melanoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Malignant Melanoma studiesPhase 2 Studies for Malignant Melanoma
🔵 Active, Not Recruiting Phase1 / Phase2
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma
📍 University of Colorado Hospital — Aurora, Colorado
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
📍 Rady Children's Hospital — San Diego, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
📍 Highlands Oncology Group ( Site 4042) — Springdale, Arkansas
View Study & Checklist ➔